Evidence map›Paper›PMID 30060606›Full record

ReviewNutrients2018

The Potential of Gut Commensals in Reinforcing Intestinal Barrier Function and Alleviating Inflammation.

Kaisa Hiippala, Hanne Jouhten, Aki Ronkainen, Anna Hartikainen, Veera Kainulainen, Jonna Jalanka, Reetta Satokari

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 331 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
331citing papers in PubMed, 6 pooled it
18.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

331 citing papers in PubMed, 6 syntheses or guidelines pooled it, 570 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Review
  11. Review
  12. Review
  13. Advances inOncology letters · 2026
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Kimchi ProbioticJournal of microbiology and biotechnology · 2026
    Article
  19. Article
  20. Article

271 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kaisa HiippalaImmunobiology Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland. kaisa.hiippala@helsinki.fi.
Hanne JouhtenImmunobiology Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland. hanne.jouhten@helsinki.fi.
Aki RonkainenImmunobiology Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland. aki.ronkainen@helsinki.fi.
Anna HartikainenImmunobiology Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland. anna.hartikainen@helsinki.fi.
Veera KainulainenPharmacology, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland. veera.kainulainen@helsinki.fi.
Jonna JalankaImmunobiology Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland. jonna.jalanka@helsinki.fi.
Reetta SatokariImmunobiology Research Program, Faculty of Medicine, University of Helsinki, 00290 Helsinki, Finland. reetta.satokari@helsinki.fi.ORCID 0000-0002-4258-3414
University of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intestinal microbiota, composed of pro- and anti-inflammatory microbes, has an essential role in maintaining gut homeostasis and functionality. An overly hygienic lifestyle, consumption of processed and fiber-poor foods, or antibiotics are major factors modulating the microbiota and possibly leading to longstanding dysbiosis. Dysbiotic microbiota is characterized to have altered composition, reduced diversity and stability, as well as increased levels of lipopolysaccharide-containing, proinflammatory bacteria. Specific commensal species as novel probiotics, so-called next-generation probiotics, could restore the intestinal health by means of attenuating inflammation and strengthening the epithelial barrier. In this review we summarize the latest findings considering the beneficial effects of the promising commensals across all major intestinal phyla. These include the already well-known bifidobacteria, which use extracellular structures or secreted substances to promote intestinal health.

Indexed as

Gastrointestinal MicrobiomeBacteriaDysbiosisFatty Acids, VolatileHumansInflammationIntestinal MucosaProbioticsFatty Acids, Volatileanti-inflammatorybutyrate producing bacteriacommensal bacteriadysbiosisintestinal healthintestinal permeabilitynext generation probiotics

Identifiers

PMID30060606
PMCPMC6116138
OpenAlexW2883138151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.